Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic therapy before prostate biopsy in asymptomatic men with elevated PSA
IRCT20180915041037N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ciprofloxacin in prostate cancer (PCa) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: PSA level and Prostate biopsy results. Started Oct 2018; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on IRCT20180915041037N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180915041037N1.